THE ROLE OF FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY GUIDED MANAGEMENT IN IMPROVING QUALITY OF LIFE AMONGST PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION

被引：0
|
作者：
Shukla, T.
Nichol, G.
Wells, G.
Garrard, L.
Guo, A.
Davies, R.
Haddad, H.
Duchesne, L.
Freeman, M.
Gulenchyn, K.
Racine, N.
Humen, D.
Benard, F.
deKemp, R.
Chen, L.
Ruddy, T.
Chow, B.
DaSilva, J.
Beanlands, R.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2011年 / 27卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2011.07.477
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 50 条
  • [1] DOES FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY GUIDED MANAGEMENT IMPROVE QUALITY OF LIFE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION? A QUALITY OF LIFE SUBSTUDY OF THE PARR2 TRIAL
    Shukla, Tushar
    Nichol, Graham
    Wells, George
    Garrard, Linda
    Guo, Ann
    Davies, Ross
    Haddad, Haissam
    Duchesne, Lloyd
    Freeman, Michael
    Gulenchyn, Karen
    Racine, Normand
    Humen, Dennis
    deKemp, Robert
    Chen, Li
    Ruddy, Terrence
    Chow, Benjamin
    DaSilva, Jean
    Beanlands, Rob
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E799 - E799
  • [2] Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction
    Chan, RKM
    Lee, KJ
    Calafiore, P
    Berlangieri, SU
    McKay, WJ
    Tonkin, AM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (07) : 1601 - 1607
  • [3] Current Role of Myocardial Viability Imaging Using Positron Emission Tomography in Patients with Chronic Ischemic Heart Failure and Left Ventricular Dysfunction
    Kjærulff M.L.G.
    Madsen S.
    Luong T.V.
    Pryds K.
    Nielsen R.
    Gormsen L.C.
    Current Cardiovascular Imaging Reports, 2023, 16 (10) : 83 - 92
  • [4] The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction
    Desideri, A
    Cortigiani, L
    Christen, AI
    Coscarelli, S
    Gregori, D
    Zanco, P
    Komorovsky, R
    Bax, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (07) : 1264 - 1269
  • [5] F-18-Fluorodeoxyglucose Positron Emission Tomography/64 MDCT Cardiac Imaging-Assisted Management of Patients with severe Left Ventricular Dysfunction
    Masselli, Gabriele G.
    Casciani, E.
    Polettini, E.
    Gualdi, G. F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0B) : S80 - S80
  • [6] Usefulness of positron emission tomography in predicting long-term outcome in patients with diabetes mellitus and ischemic left ventricular dysfunction
    Sawada, S
    Hamoui, O
    Barclay, J
    Giger, S
    Fain, R
    Foltz, J
    Fineberg, N
    Hutchins, G
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (01): : 2 - 8
  • [7] The role of F-18-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma
    Kadhim, Lujaien A.
    Dholakia, Avani S.
    Herman, Joseph M.
    Lwahl, Richard
    Chaudhry, Muhammad A.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (04) : 341 - 352
  • [8] Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma
    Deshmukh, A
    Scott, JA
    Palmer, EL
    Hochberg, FH
    Gruber, M
    Fischman, AJ
    CLINICAL NUCLEAR MEDICINE, 1996, 21 (09) : 720 - 725
  • [9] A stent model of left ventricular dysfunction: Validation using positron emission tomography
    Mesotten, L
    Maes, A
    Szilard, M
    Nuyts, J
    Bormans, G
    Wang, K
    Borgers, M
    De Scheerder, I
    Mortelmans, L
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 142P - 142P
  • [10] Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
    Thangamuthu, Brithika Yoganayaki
    Elangovan, Indirani
    Asra, Patel
    Simon, Shelley
    Sathyamoorthy, Immaneni
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 38 (02): : 110 - 114
12345